Abstract
Paclitaxel (Taxol) is a naturally occurring member of the taxane family of antitumor drugs, which act by stabilizing microtubules. Paclitaxel is inactivated in human liver by a cytochrome P450 (P450)-catalyzed 6α-hydroxylation reaction. A reverse-phase, high-performance liquid chromatographic assay is described for the analysis of paclitaxel 6α-hydroxylation catalyzed by human liver microsomes or cDNA-expressed P450 enzyme CYP2C8. Analytical separations are achieved using a C18 column with a linear gradient of 10–100% methanol, with detection at 230 nm. This method is applicable to enzymatic studies for determination of CYP2C8-catalyzed paclitaxel 6α-hydroxylation activity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Romkes, M., Faletto, M. B., Blaisdell, J. A., Raucy, J. L., and Goldstein, J. A. (1991) Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry 30, 3247–3255.
Wrighton, S. A., VandenBranden, M., Stevens, J. C., Shipley, L. A., and Ring, B. J. (1993) In vitro methods for assessing human hepatic drug metabolism: their use in drug development. Drug Metab. Rev. 25, 453–484.
Goldstein, J. A., Faletto, M. B., Romkes-Sparks, M., et al. (1994) Evidence that CYP2C19 is the major (S)-mephenytoin 4′-hydroxylase in humans. Biochemistry 33, 1743–1752.
Chang, T. K. H., Yu, L., Maurel, P., and Waxman, D. J. (1997) Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines. Cancer Res. 57, 1946–1954.
Wrighton, S. A., Thomas, P. E., Willis, P., et al. (1987) Purification of a human liver cytochrome P-450 immunochemically related to several cytochromes P-450 purified from untreated rats. J. Clin. Invest. 80, 1017–1022.
Leo, M. A., Lasker, J. M., Raucy, J. L., Kim, C. I., Black, M., and Lieber, C. S. (1989) Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8. Arch. Biochem. Biophys. 269, 305–312.
Wen, X., Wang, J. S., Backman, J. T., Laitila, J., and Neuvonen, P. J. (2002) Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively. Drug Metab. Dispos. 30, 631–635.
Nadin, L. and Murray, M. (1999) Participation of CYP2C8 in retinoic acid 4-hydroxylation in human hepatic microsomes. Biochem. Pharmacol. 58, 1201–1208.
Daikh, B. E., Lasker, J. M., Raucy, J. L., and Koop, D. R. (1994) Regio-and stereoselective epoxidation of arachidonic acid by human cytochromes P450 2C8 and 2C9. J. Pharmacol. Exp. Ther. 271, 1427–1433.
Rifkind, A. B., Lee, C., Chang, T. K. H., and Waxman, D. J. (1995) Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. Arch. Biochem. Biophys. 320, 380–389.
Ohyama, K., Nakajima, M., Nakamura, S., Shimada, N., Yamazaki, H., and Yokoi, T. (2000) A significant role of human cytochrome P450 2C8 in amiodarone N-deethylation: an approach to predict the contribution with relative activity factor. Drug Metab. Dispos. 28, 1303–1310.
Kerr, B. M., Thummel, K. E., Wurden, C. J., et al. (1994) Human liver carbamazepine metabolism: role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochem. Pharmacol. 47, 1969–1979.
Projean, D., Morin, P. E., Tu, T. M., and Ducharme, J. (2003) Identification of CYP3A4 and CYP2C8 as the major cytochrome P450s responsible for morphine N-demethylation in human liver microsomes. Xenobiotica 33, 841–854.
Wang, J. S. and DeVane, C. L. (2003) Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)-and (S)-methadone in vitro. Drug Metab. Dispos. 31, 742–747.
Li, X. Q., Bjorkman, A., Andersson, T. B., Ridderstrom, M., and Masimirembwa, C. M. (2002) Amodiaquine clearance and its metabolism to N-desethyamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate. J. Pharmacol. Exp. Ther. 300, 399–407.
Rahman, A., Korzekwa, K. R., Grogan, J., Gonzalez, F. J., and Harris, J. W. (1994) Selective biotransformation of taxol to 6α-hydroxytaxol by human cytochrome P450 2C8. Cancer Res. 54, 5543–5546.
Sonnichsen, D. S., Liu, Q., Schuetz, E. G., Schuetz, J. D., Pappo, A., and Relling, M. V. (1995) Variability in human cytochrome P450 paclitaxel metabolism. J. Pharmacol. Exp. Ther. 275, 566–575.
Richardson, T. H., Jung, F., Griffin, K. J., et al. (1995) A universal approach to the expression of human and rabbit cytochrome P450s of the 2C subfamily in Escherichia coli. Arch. Biochem. Biophys. 323, 87–96.
Krausz, K. W., Goldfarb, I., Buters, J. T. M., Yang, T. J., Gonzalez, F. J., and Gelboin, H. V. (2001) Monoclonal antibodies specific and inhibitory to human cytochromes P450 2C8, 2C9, and 2C19. Drug Metab. Dispos. 29, 1410–1423.
Song, D., Hsu, L. F., and Au, J. L. S. (1996) Binding of Taxol to plastic and glass containers and protein under in vitro conditions. J. Pharm. Sci. 85, 29–31.
Pearce, R. E., McIntyre, C. J., Madan, A., et al. (1996) Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity. Arch. Biochem. Biophys. 331, 145–169.
Busby W. F. Jr., Ackermann, J. M., and Crespi, C. L. (1999) Effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P-450. Drug Metab. Dispos. 27, 246–249.
Acknowledgments
This work was supported in part by the Canadian Institutes of Health Research (grant MOP-42385) and the National Institutes of Health (grant CA49248).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Crespi, C.L., Chang, T.K.H., Waxman, D.J. (2006). High-Performance Liquid Chromatography Analysis of CYP2C8-Catalyzed Paclitaxel 6α-Hydroxylation. In: Phillips, I.R., Shephard, E.A. (eds) Cytochrome P450 Protocols. Methods in Molecular Biology, vol 320. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-998-2:103
Download citation
DOI: https://doi.org/10.1385/1-59259-998-2:103
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-58829-441-8
Online ISBN: 978-1-59259-998-1
eBook Packages: Springer Protocols